Work

P2.08-06 A Phase II Study of Subcutaneous (SC) Atezolizumab in NSCLC Patients Using a Decentralized Clinical Trial Model

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.573

Authors: E.R. Qi, A. Zheng, L.P. Nocera, A. Kolatkar, P. Kuhn, J. Nieva

Institution: University of Southern California

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388045346

FWCI: 0.122

Cites:

Cited by: 1

Related to: 10